ConductScience.org, home

Paper55892

Breast-cancer osteolysis, bone metastases, and anti-osteolytic effect of aspirin.

Powles TJ and 4 others. Lancet, 1976. Cited by 115 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Breast-cancer osteolysis, bone metastases, and anti-osteolytic effect of aspirin. Papers, record 55892. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/55892

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Breast-cancer osteolysis, bone metastases, and anti-osteolytic effect of aspirin.
PubMed
Journal
Lancet
PubMed
Year
1976
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
115
iCite
Relative citation ratio, by iCite
3.5
iCite
Revised in PubMed
2019-06-10
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Powles TJT J
2Dowsett MM
3Easty GCG C
4Easty DMD M
5Neville AMA M

Source PubMed

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AspirinMajor topic
Bone NeoplasmsMajor topic
Bone ResorptionMajor topic
Breast NeoplasmsMajor topic
Neoplasm MetastasisMajor topic
OsteolysisMajor topic
Animals
Bone and Bones
Calcium
Culture Techniques
Cyclooxygenase Inhibitors
Female
Humans
Hypercalcemia
Mice
Paraneoplastic Endocrine Syndromes

Source PubMed

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 115 citations.

PMIDTitleJournalYearIn PapersSource
36,099,932Aspirin and cancer: biological mechanisms and clinical outcomes.Open Biol2022https://conductscience.org/library/papers/36099932PubMed
34,485,279miRNA-7062-5p Promoting Bone Resorption After Bone Metastasis of Colorectal Cancer Through Inhibiting GPR65.Front Cell Dev Biol2021https://conductscience.org/library/papers/34485279PubMed
30,461,194Small molecule nAS-E targeting cAMP response element binding protein (CREB) and CREB-binding protein interaction inhibits breast cancer bone metastasis.J Cell Mol Med2019https://conductscience.org/library/papers/30461194PubMed
27,303,926Molecular and genetic inflammation networks in major human diseases.Mol Biosyst2016https://conductscience.org/library/papers/27303926PubMed
24,140,083Targeting tumor-stromal interactions in bone metastasis.Pharmacol Ther2014https://conductscience.org/library/papers/24140083PubMed
23,388,178Non-steroid anti-inflammatory drugs, prostaglandins, and cancer.Cell Biosci2013https://conductscience.org/library/papers/23388178PubMed
22,439,092Metastatic spinal tumor.Asian Spine J2012https://conductscience.org/library/papers/22439092PubMed
8,347,847Mechanisms involved in the metastasis of cancer to bone.Breast Cancer Res Treat1993https://conductscience.org/library/papers/8347847PubMed
7,773,580The management of hypercalcemia of malignancy.Support Care Cancer1995https://conductscience.org/library/papers/7773580PubMed
7,470,384In vitro osteolytic activity of human breast carcinoma tissue and prognosis.Br J Cancer1981https://conductscience.org/library/papers/7470384PubMed
7,383,949Hypercalcaemia in malignant lymphoma.Postgrad Med J1980https://conductscience.org/library/papers/7383949PubMed
7,370,160Prostaglandin-like material extracted from squamous carcinomas of the head and neck.Br J Cancer1980https://conductscience.org/library/papers/7370160PubMed
7,216,714Differentiation of hypercalcaemia due to malignancy from primary hyperparathyroidism: the value of parathyroid hormone and plasma bicarbonate measurements.Ir J Med Sci1981https://conductscience.org/library/papers/7216714PubMed
7,104,197Failure of short-term treatment with flurbiprofen to enhance the therapeutic effect of cyclophosphamide against rodent sarcomas and a leukaemia.Br J Cancer1982https://conductscience.org/library/papers/7104197PubMed
6,688,732Suppression of plasma 6-keto-prostaglandin F1 alpha and 13,14-dihydro-15-keto-prostaglandin F2 alpha by aminoglutethimide in advanced breast cancer.Br J Cancer1983https://conductscience.org/library/papers/6688732PubMed
6,580,033Further observations on mechanisms of bone destruction by squamous carcinomas of the head and neck: the role of host stroma.Br J Cancer1983https://conductscience.org/library/papers/6580033PubMed
3,859,318Prostaglandin F2 alpha in benign and malignant breast tumours.Br J Cancer1985https://conductscience.org/library/papers/3859318PubMed
3,855,865Estrogens and antiestrogens stimulate release of bone resorbing activity by cultured human breast cancer cells.J Clin Invest1985https://conductscience.org/library/papers/3855865PubMed
3,593,988Inhibition by indomethacin of spontaneous mammary tumorigenesis in SHN mice.Breast Cancer Res Treat1986https://conductscience.org/library/papers/3593988PubMed
3,094,242Histomorphometric analysis of osteoclastic bone resorption in metastatic bone disease from various primary malignomas.Virchows Arch A Pathol Anat Histopathol1986https://conductscience.org/library/papers/3094242PubMed

See all 30 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/55892

GET https://conductscience.org/api/papers/v1/55892/cited_by?page=2